These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. Ruzza C; Rizzi A; Trapella C; Pela' M; Camarda V; Ruggieri V; Filaferro M; Cifani C; Reinscheid RK; Vitale G; Ciccocioppo R; Salvadori S; Guerrini R; Calo' G Peptides; 2010 May; 31(5):915-25. PubMed ID: 20172007 [TBL] [Abstract][Full Text] [Related]
33. Behavioural alterations in male mice lacking the gene for D-aspartate oxidase. Weil ZM; Huang AS; Beigneux A; Kim PM; Molliver ME; Blackshaw S; Young SG; Nelson RJ; Snyder SH Behav Brain Res; 2006 Aug; 171(2):295-302. PubMed ID: 16725213 [TBL] [Abstract][Full Text] [Related]
34. Purkinje cell loss affects differentially the execution, acquisition and prepulse inhibition of skeletal and facial motor responses in Lurcher mice. Porras-García E; Cendelin J; Domínguez-del-Toro E; Vozeh F; Delgado-García JM Eur J Neurosci; 2005 Feb; 21(4):979-88. PubMed ID: 15787704 [TBL] [Abstract][Full Text] [Related]
35. Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity. Galici R; Boggs JD; Miller KL; Bonaventure P; Atack JR Behav Pharmacol; 2008 Mar; 19(2):153-9. PubMed ID: 18332680 [TBL] [Abstract][Full Text] [Related]
36. Delayed onset of prepulse inhibition deficits following kainic acid treatment on postnatal day 7 in rats. Howland JG; Hannesson DK; Phillips AG Eur J Neurosci; 2004 Nov; 20(10):2639-48. PubMed ID: 15548207 [TBL] [Abstract][Full Text] [Related]
37. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins. Spencer CM; Serysheva E; Yuva-Paylor LA; Oostra BA; Nelson DL; Paylor R Hum Mol Genet; 2006 Jun; 15(12):1984-94. PubMed ID: 16675531 [TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1. Camarda V; Ruzza C; Rizzi A; Trapella C; Guerrini R; Reinscheid RK; Calo G Peptides; 2013 Oct; 48():27-35. PubMed ID: 23911665 [TBL] [Abstract][Full Text] [Related]
39. Abnormal response to stress and impaired NPS-induced hyperlocomotion, anxiolytic effect and corticosterone increase in mice lacking NPSR1. Zhu H; Mingler MK; McBride ML; Murphy AJ; Valenzuela DM; Yancopoulos GD; Williams MT; Vorhees CV; Rothenberg ME Psychoneuroendocrinology; 2010 Sep; 35(8):1119-32. PubMed ID: 20171785 [TBL] [Abstract][Full Text] [Related]